Immuron (IMRN) Liabilities and Shareholders Equity (2016 - 2025)

Immuron (IMRN) recorded quarterly Liabilities and Shareholders Equity of $100926.2 in Q3 2025, down 98.44% quarter-over-quarter from $6.5 million in Q2 2025, and down 35.1% on a YoY basis from $155499.7 in Q3 2024.

Immuron (IMRN) Liabilities and Shareholders Equity (2016 - 2025) Analysis & Trends

Immuron's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $100926.2 for Q3 2025.

  • In Q3 2025, Liabilities and Shareholders Equity fell 35.1% year-over-year to $100926.2; the TTM figure through Sep 2025 stood at $14.7 million (down 41.06% YoY), while the FY2025 annual figure was $100926.2, down 35.1% from the prior year.
  • Liabilities and Shareholders Equity was $100926.2 for Q3 2025 at Immuron, down from $6.5 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $20.8 million in Q2 2021 to a low of $100926.2 in Q3 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $9.1 million across 5 years, with a median of $9.1 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity jumped 8691.06% in 2022, then sank 99.21% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $185766.3 in 2021, then surged by 8691.06% to $16.3 million in 2022, then slumped by 99.21% to $129434.6 in 2023, then surged by 6048.66% to $8.0 million in 2024, then tumbled by 98.73% to $100926.2 in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $100926.2 (Q3 2025), $6.5 million (Q2 2025), and $8.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Immuron 921.61 Mn 921.58 Mn - 100,926.19

Historic Data

Download Data
DateValue
Sep 2, 2025 100,926.19
Jun 30, 2025 6.49 Mn
Dec 31, 2024 7.96 Mn
Sep 9, 2024 155,499.69
Jun 30, 2024 10.25 Mn
Dec 31, 2023 129,434.59
Sep 28, 2023 14.41 Mn
Aug 30, 2023 219,881.82
Jun 30, 2023 14.70 Mn
Dec 31, 2022 16.33 Mn
Aug 31, 2022 17.29 Mn
Jun 30, 2022 17.80 Mn
Dec 31, 2021 185,766.29
Jun 30, 2021 20.83 Mn
Dec 31, 2020 290,636.97
Sep 1, 2020 6.20 Mn
Jun 30, 2020 4.07 Mn
Dec 31, 2019 62,021.63
Jun 30, 2019 6.00 Mn
Dec 31, 2018 7.70 Mn